The FDA has updated the labeling for Camzyos to reduce echocardiogram monitoring requirements for patients in the maintenance phase and contraindications.

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an ...

Unfortunately, our NAD levels decline steadily after 30, which researchers believe contributes to fatigue, slower metabolism, and other hallmarks of aging​. The good news? Boosting NAD through ...